Paradiem LLC Cuts Stock Position in Nutrien Ltd. (NYSE:NTR)

Paradiem LLC lowered its stake in Nutrien Ltd. (NYSE:NTRFree Report) by 36.4% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 8,148 shares of the company’s stock after selling 4,661 shares during the period. Paradiem LLC’s holdings in Nutrien were worth $459,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in NTR. Legacy Financial Group LLC purchased a new stake in shares of Nutrien in the 3rd quarter worth approximately $28,000. Exchange Traded Concepts LLC lifted its position in Nutrien by 904.0% in the 4th quarter. Exchange Traded Concepts LLC now owns 753 shares of the company’s stock valued at $42,000 after acquiring an additional 678 shares in the last quarter. Evolution Advisers Inc. bought a new position in Nutrien in the 4th quarter valued at approximately $49,000. CVA Family Office LLC bought a new position in Nutrien in the 4th quarter valued at approximately $57,000. Finally, NBC Securities Inc. bought a new position in Nutrien in the 3rd quarter valued at approximately $58,000. Hedge funds and other institutional investors own 63.10% of the company’s stock.

Nutrien Stock Performance

Shares of NYSE:NTR traded up $0.50 during midday trading on Friday, hitting $52.55. The company had a trading volume of 1,227,851 shares, compared to its average volume of 1,711,381. Nutrien Ltd. has a 12-month low of $47.90 and a 12-month high of $70.07. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.17 and a quick ratio of 0.65. The company has a market cap of $25.99 billion, a price-to-earnings ratio of 20.77, a PEG ratio of 1.96 and a beta of 0.89. The company has a fifty day moving average of $53.23 and a two-hundred day moving average of $54.03.

Nutrien (NYSE:NTRGet Free Report) last issued its quarterly earnings results on Wednesday, February 21st. The company reported $0.37 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.72 by ($0.35). Nutrien had a return on equity of 8.59% and a net margin of 4.33%. The business had revenue of $5.66 billion during the quarter, compared to analysts’ expectations of $5.36 billion. During the same quarter in the previous year, the company posted $2.02 EPS. The company’s quarterly revenue was down 24.8% on a year-over-year basis. On average, equities research analysts expect that Nutrien Ltd. will post 3.82 EPS for the current fiscal year.

Nutrien Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, April 11th. Shareholders of record on Thursday, March 28th were paid a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 4.11%. The ex-dividend date of this dividend was Wednesday, March 27th. This is a positive change from Nutrien’s previous quarterly dividend of $0.53. Nutrien’s dividend payout ratio is presently 85.38%.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Royal Bank of Canada lowered their price objective on Nutrien from $75.00 to $70.00 and set an “outperform” rating on the stock in a research report on Friday, February 23rd. BMO Capital Markets lowered their price objective on Nutrien from $86.00 to $80.00 and set an “outperform” rating on the stock in a research report on Thursday, January 25th. TD Securities lowered their price objective on Nutrien from $75.00 to $67.00 and set a “buy” rating on the stock in a research report on Tuesday, February 20th. Wolfe Research initiated coverage on Nutrien in a report on Friday, March 1st. They set an “outperform” rating and a $66.00 price target on the stock. Finally, Stifel Nicolaus increased their price target on Nutrien from $72.00 to $75.00 and gave the company a “buy” rating in a report on Friday, January 19th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, Nutrien presently has an average rating of “Hold” and a consensus target price of $67.95.

View Our Latest Research Report on NTR

Nutrien Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Read More

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.